Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
November 3, 2022 10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 8, 2023 10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 28, 2023 10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 8, 2023 10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 12, 2014 8-A12B

Registration of certain classes of securities 12(b) of the Securities Exchange Act

View HTML
October 1, 2018 S-4

Registration of securities issued in business combination transactions

View HTML
March 19, 2014 S-1MEF

Registration of up to an additional 20% of securities for any offering registered on an S-1

View HTML
February 14, 2014 S-1

Registration statement for face-amount certificate companies

View HTML
March 28, 2014 8-K

Report of unscheduled material events or corporate event

View HTML
July 17, 2014 8-K

Report of unscheduled material events or corporate event

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us